The approval of etofenprox as an active substance for use in biocidal products of product-types 8 and 18 is not renewed.
資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex
Commission Implementing Decision (EU) 2026/378 of 20 February 2026 not renewing the approval of etofenprox for use in biocidal products of product-types 8 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Treated articles treated with or intentionally incorporating etofenprox for use in biocidal products of product-types 8 and 18 shall no longer be placed on the market as from 11 September 2026.
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
Cite this act
Commission Implementing Decision (EU) 2026/378 of 20 February 2026 not renewing the approval of etofenprox for use in biocidal products of product-types 8 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32026D0378
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com